Northrop Grumman Corporation
NYSE:NOCAerospace & Defense
-$32.91 today
- Market cap
- $77.14B
- Beta
- -0.12
- P/E (TTM)
- 16.1
- EPS (TTM)
- $32.20
- Dividend yield
- 1.82%
Volume 0.86M
Average 0.86M
NOC Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Northrop Grumman CorporationNYSE: NOC
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents rises 91.3% from a year ago
Cash & equivalents stood at $3.74B at the end of Q3 FY2026, up 91.3% from a year earlier and up 62.3% from the prior quarter. Over 3 fiscal years it compounded at +19.5% a year.
Context
- Cash & equivalents amounted to 7.1% of total assets at the end of Q3 FY2026, up 3.2 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +91.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 4.4B USD
- Year-over-year change
- +1.1%
- 4-year CAGR
- +5.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.4B | +1.1% |
| FY2024 | 2024-12-31 | 4.35B | +40.0% |
| FY2023 | 2023-12-31 | 3.11B | +20.6% |
| FY2022 | 2022-12-31 | 2.58B | -27.0% |
| FY2021 | 2021-12-31 | 3.53B | — |
Cash & Equivalents vs competitors
How NOC compares with its peers on the latest reported figures
- NOC's Sep 2026 cash & equivalents of $3.74B is the 5th highest of the 7 companies compared; the peer median is $5.17B.
- Its year-over-year change of +91.3% is the 2nd highest of 7, against a peer median of +62.8%.
- Cash & equivalents amounts to 7.1% of total assets for NOC, versus a peer median of 4.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $9.17B | +53.8% | +6.1% | 5.2% | |
| Jun 2026 | $7.24B | +2.1% | -9.3% | 4.4% | |
| Sep 2026 | $5.96B | +71.8% | +17.4% | 9.2% | |
| Oct 2026 | $4.39B | +74.1% | +23.4% | 7.3% | |
| Sep 2026 | $3.74B | +91.3% | +19.5% | 7.1% | |
| Jul 2026 | $1.52B | +215.6% | +6.7% | 3.5% | |
| Jun 2026 | $12M | -96.5% | +18.3% | 0.1% | |
| Peer median (excluding NOC) | $5.17B | +62.8% | +12.0% | 4.8% | |
Competitors are the stored peer set for NOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.53B | 2.58B | 3.11B | 4.35B | 4.4B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 6.96B | 7.49B | 8.65B | 7.7B | 8.84B |
| Inventory | 811M | 978M | 1.11B | 1.46B | 1.31B |
| Other Current Assets | 944M | 1.26B | 635M | 583M | 543M |
| Total Current Assets | 12.24B | 12.31B | 13.5B | 14.09B | 15.1B |
| Property, Plant & Equipment (Net) | 9.55B | 10.61B | 11.47B | 12.31B | 12.83B |
| Goodwill | 17.52B | 17.52B | 17.52B | 17.51B | 17.44B |
| Intangible Assets | 578M | 384M | 305M | 254M | 208M |
| Long-term Investments | 418M | 332M | 339M | 347M | 483M |
| Tax Assets | 200M | 162M | 1.02B | 1.6B | 1.05B |
| Other Non-current Assets | 1.89B | 2.26B | 2.19B | 3.25B | 4.27B |
| Total Non-current Assets | 30.15B | 31.27B | 32.84B | 35.27B | 36.28B |
| Total Assets | 42.58B | 43.76B | 46.54B | 49.36B | 51.38B |
| Account Payables | 2.2B | 2.59B | 2.11B | 2.6B | 3.24B |
| Short-term Debt | 290M | 1.37B | 370M | 1.91B | 865M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.03B | 3.61B | 4.19B | 4.07B | 4.09B |
| Other Current Liabilities | 2.02B | 1.96B | 3.02B | 3.28B | 3.38B |
| Total Current Liabilities | 9.53B | 11.59B | 11.94B | 14.13B | 13.88B |
| Long-term Debt | 14.37B | 13.63B | 15.68B | 16.49B | 17.02B |
| Deferred Tax Liabilities | 490M | 132M | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3.68B | 1.27B | 2.24B | 1.65B | 1.95B |
| Total Non-current Liabilities | 20.12B | 16.86B | 19.81B | 19.94B | 20.82B |
| Total Liabilities | 29.65B | 28.44B | 31.75B | 34.07B | 34.7B |
| Common Stock | 156M | 153M | 150M | 145M | 142M |
| Retained Earnings | 12.91B | 15.31B | 14.77B | 15.3B | 16.66B |
| Accumulated OCI | (143M) | (153M) | (128M) | (152M) | (126M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 12.93B | 15.31B | 14.8B | 15.29B | 16.67B |
| Total Debt | 16.25B | 16.82B | 17.94B | 20.19B | 19.74B |
| Net Debt | 12.72B | 14.25B | 14.83B | 15.84B | 15.34B |
Northrop Grumman Corporation
NYSE:NOC
Intrinsic Alpha fair value
Locked
Current Price
$542.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.